Earnings Feed
Start Free
Home/Filings/4/0001225208-15-011278
4//SEC Filing

Merck & Co., Inc. 4

Accession 0001225208-15-011278

$MRKCIK 0000310158operating
View on SEC.govCompany Profile

Filed

May 4, 8:00 PM ET

Accepted

May 5, 4:46 PM ET

Size

10.3 KB

Accession

0001225208-15-011278

Insider Transaction Report

Form 4
Period: 2015-05-01
Merck & Co., Inc.MRK
Rosenblatt Michael
Exec V-P & Chief Med Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2015-05-02$59.86/sh−3,818$228,545→ 0 total
    From: 2015-05-02Exp: 2015-05-02→ Common Stock (3,818 underlying)
  • Award

    Stock Option (right to buy)

    2015-05-01+46,440→ 46,440 total
    Exercise: $59.86From: 2016-05-01Exp: 2025-04-30→ Common Stock (46,440 underlying)
  • Exercise/Conversion

    Common Stock

    2015-05-02+3,818→ 34,533.64 total
  • Tax Payment

    Common Stock

    2015-05-02$59.86/sh−1,980$118,523→ 32,553.64 total
Footnotes (3)
  • [F1]Holdings include shares acquired in dividend reinvestment transactions.
  • [F2]The option vests and becomes exercisable in three equal installments on 5/1/2016, 5/1/2017 and 5/1/2018.
  • [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

Documents

1 file

Issuer

Merck & Co., Inc.

CIK 0000310158

→
Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0000310158

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 4:46 PM ET
Size
10.3 KB
View on SEC.gov